Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Antonio M, Serafin"'
Publikováno v:
International Journal of Radiation Biology. 99:292-307
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ed5a7e2cf371b0ce41d1d7915fad4af
https://doi.org/10.1080/09553002.2022.2074164
https://doi.org/10.1080/09553002.2022.2074164
Publikováno v:
Plasma Medicine. 12:27-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a58c81a7159119b6b6778818090a23
https://doi.org/10.1615/plasmamed.2022044536
https://doi.org/10.1615/plasmamed.2022044536
Publikováno v:
EMJ Urology.
Background: A fine balance exists between the early treatment of a potentially lethal prostate disease and possible complications from the early treatment of a potentially indolent disease. Prostate-specific antigen (PSA) is an indicator of disease p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45bc7986df0337bb3689ca8fb6080021
https://doi.org/10.33590/10.33590/emjurol/21-00116
https://doi.org/10.33590/10.33590/emjurol/21-00116
Publikováno v:
Discovery medicine. 29(158)
The objective of this study was to validate the results from our published work and to test the robustness of our unique malignancy index as a (non-invasive) predictor of prostate cancer in fresh blood samples obtained from patients diagnosed with pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5ee610da96c0b886a880b70e3eb42ac
https://pubmed.ncbi.nlm.nih.gov/33007193
https://pubmed.ncbi.nlm.nih.gov/33007193
Publikováno v:
Discovery medicine. 25(139)
No unambiguous role of the involvement of uroplasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in prostate cancer has emerged, with current evidence suggesting that neither biomarker is likely of significant clinical valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ac40a3a161cffcfcae52f93b3ea23be
https://pubmed.ncbi.nlm.nih.gov/29906406
https://pubmed.ncbi.nlm.nih.gov/29906406
Autor:
Therina, du Toit, Liezl M, Bloem, Jonathan L, Quanson, Riaan, Ehlers, Antonio M, Serafin, Amanda C, Swart
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 166
Adrenal C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b15952d138a274949d938818d67da8f
https://pubmed.ncbi.nlm.nih.gov/27345701
https://pubmed.ncbi.nlm.nih.gov/27345701
Autor:
Antonio M. Serafin, Lothar Böhm
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 23:123-129
The administration of cancer chemotherapeutic agents results in an increase in the apoptotic cells in the tumor: therefore, it has been assumed that anticancer drugs exhibit their cytotoxic effects via apoptotic signaling pathways. Characteristics th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f24edb626eaacb644e7365d3758b3bb
https://doi.org/10.1016/j.urolonc.2004.11.007
https://doi.org/10.1016/j.urolonc.2004.11.007
Publikováno v:
Urological research. 30(5)
Chemotherapeutic drug resistance remains a significant obstacle in the control of prostate cancer. The influence of p53 and androgen status on the drug response of new cell lines from normal, benign and primary tumour epithelium was investigated. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a5d1be227ec4d83eea10411d7f14e6
https://pubmed.ncbi.nlm.nih.gov/12389116
https://pubmed.ncbi.nlm.nih.gov/12389116